NEW YORK, NY / ACCESS Newswire / June 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading LUNC price dives after Do Kwon sentence: here’s why it may dive by 45%.